VILDAMET 50 MG/1000MG
Patients with type 2 diabetes mellitus (T2DM): VILDAMET is indicated for adjuvant treatment with diet and physical activity in patients in whom monotherapy with metformin hydrochloride or vildagliptin has failed to achieve sufficient blood sugar control, or in patients already on treatment with a free combination of metformin hydrochloride and vildagliptin. VILDAMET is indicated in combination with a sulfonylurea (i.e. triplicate) for adjuvant therapy with diet and physical activity in patients in whom treatment with metformin and a sulfonylurea does not allow alone to achieve sufficient blood sugar control. VILDAMET is indicated in combination with insulin to improve blood sugar control in patients in whom diet, physical activity, and treatment with a stable dose of insulin and metformin do not achieve control. sufficient blood sugar.